The role of CRMP4 in LPS-induced neuroinflammation
Brain Research · 2024
DOI: 10.1016/j.brainres.2024.149094 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain Research, 2024. Verfasst von Ryo Asahina und 6 weiteren Autor:innen. Beteiligte Einrichtung: Departent of Life Science and Medical Bioscience, Waseda University, Japan. Hauptthemen laut MEDLINE: Lipopolysaccharides, Microglia, Mice, Knockout, Nerve Tissue Proteins. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 34 Literaturangaben.
Abstract (Originalsprache)
Neuroinflammation has been gaining attention as one of the potential causes of neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis in recent years. The suppression of excessive proinflammatory responses is expected to be a target for the treatment and prevention of neurodegenerative diseases. Collapsin response mediator protein 4 (CRMP4) is involved in cytoskeleton-associated axonal guidance in the developing brain. Recently, the involvement of CRMP4 in several pathological conditions, including inflammation induced by lipopolysaccharide (LPS), a widely used inflammatory molecule, has been reported. However, the role of CRMP4 in LPS-induced inflammation in vivo remains largely unknown. In this study, we generated microglia-specific CRMP4 knockout mice for the first time and examined the role of CRMP4 in an LPS-induced brain inflammation model. We found that microglia after LPS injection in substantia nigra was significantly reduced in Crmp4-/- mice compared to Crmp4+/+mice. The increased expression of IL-10 in striatum samples was downregulated in Crmp4-/- mice. A significant reduction in Iba1 expression was also observed in microglia-specific Crmp4 knockout mice compared with that in control mice. In contrast, the expression of IL-10 did not change in these mice, whereas arginase 1 (Arg1) expression was significantly suppressed. These results demonstrate the involvement of CRMP4 in LPS-induced inflammation in vivo, that CRMP4 suppresses microglial proliferation in a cell-autonomous manner.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Departent of Life Science and Medical Bioscience, Waseda University, Japan.
- Department of Cell Biology, The Cancer Institute of JFCR, Japan.
- Department of Animal Model Development, Brain Research Institute, Niigata University, Japan.
- Department of Molecular Pharmacology and Neurobiology, Yokohama City University Graduate School of Medicine, Yokohama 236-0004, Japan.
- Departent of Life Science and Medical Bioscience, Waseda University, Japan. Electronic address: ohshima@waseda.jp.
Zitieren
APA
Asahina, R., Takahashi, M., Takano, H., Yao, R., Abe, M., Goshima, Y., & Ohshima, T. (2024). The role of CRMP4 in LPS-induced neuroinflammation. Brain Research. https://doi.org/10.1016/j.brainres.2024.149094
Vancouver
Asahina R, Takahashi M, Takano H, Yao R, Abe M, Goshima Y, et al. The role of CRMP4 in LPS-induced neuroinflammation. Brain Research. 2024. doi:10.1016/j.brainres.2024.149094
BibTeX
@article{Asahina2024,
author = {Asahina, Ryo and Takahashi, Miyuki and Takano, Hiroshi and Yao, Ryoji and Abe, Manabu and Goshima, Yoshio and Ohshima, Toshio},
title = {The role of CRMP4 in LPS-induced neuroinflammation},
journal = {Brain Research},
year = {2024},
doi = {10.1016/j.brainres.2024.149094}
}
EUVIMED